Cabaletta Bio Inc
Veridion Score
Composite trend over time
Why is CABA moving today?
Cabaletta Bio Inc is a late clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies for autoimmune diseases. Its proprietary Cabaletta Approach to B cell Ablation (CABA) platform includes the CARTA approach, which uses chimeric antigen receptor T cells to eliminate B cells and potentially reset the immune system. The company develops cellular therapies including CAR T and CAAR T product candidates. Its candidate, rese-cel (resecabtagene autoleucel), a CD19-CAR T cell therapy, is being evaluated in Phase 1/2 trials for autoimmune diseases such as systemic lupus erythematosus, myositis, systemic sclerosis, generalized myasthenia gravis, and pemphigus vulgaris.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Warehouse intelligence for CABA.
CABA insider activity
Cabaletta Bio Inc
No multi-insider buying cluster in the last 90 days
Net buying: $296K across loaded Form 4 rows.
Loaded official disclosures do not show all three sources aligned on this ticker.
| Filing date | Trade date | Insider | Title | Type | Price | Qty | Owned | Value | Receipt |
|---|---|---|---|---|---|---|---|---|---|
| 2026-01-21 | 2026-01-21 | Chang David J. | Insider | buy | $2.26 | 8,800 | 8,800 | $20K | SEC Form 4 |
| 2026-01-21 | 2026-01-21 | Binder Gwendolyn | Insider | buy | $2.19 | 11,312 | 31,312 | $25K | SEC Form 4 |
| 2026-01-21 | 2026-01-21 | Gavel Steve | Insider | buy | $2.27 | 22,170 | 22,170 | $50K | SEC Form 4 |
| 2026-01-21 | 2026-01-21 | Bollard Catherine | Insider | buy | $2.27 | 4,405 | 5,405 | $10K | SEC Form 4 |
| 2026-01-21 | 2026-01-21 | Gerard Michael | Insider | buy | $2.27 | 6,600 | 6,600 | $15K | SEC Form 4 |
Showing 5 recent rows. Sovereign unlocks 3 additional rows, full sorting, and the named-filer history.
Upgrade to Sovereign · $25/moCABA contract awards, year to date.
Public federal awards linked to this ticker.
CABA lobbying filings, year to date.
Registered lobbying filings matched to Cabaletta Bio Inc.